TRANSPORT OF PATIENTS FOR PRIMARY PTCA FROM GENERAL HOSPITAL NOVO MESTO TO LJUBLJANA IN 2002
Background. The treatment of acute coronary syndrome (ACS) with ST-segment elevation with primary percutaneous transluminal coronary angioplasty (PTCA) is the best way to treat these patients. Primary PTCA is also practicable with patients who are admitted into institution without catheter laboratory. The transport of patients into the tertiary institution is safe, but it is important to keep the time of ischemia as short as possible and to reach the time interval of door-balloon as recommended by the guidelines. The ACS patients with ST-segment elevation that were directed into General Hospital Novo mesto after examination at the internistic emergency department have been redirected to KC Ljubljana for realization of PTCA since October 2001.
Methods. A prospective analysis of patients with ACS with STsegment elevation, who had been transferred from General Hospital Novo mesto to KC Ljubljana in the period from January 1, 2002 to December 31, 2002 to have a primary PTCA, was performed. The analysis comprised the following: the time interval of handling the patients at Internistic department of General Hospital Novo mesto, the time of transport of patients to Ljubljana and total time interval from the arrival of patients to General Hospital Novo mesto to the first inflation of balloon in Ljubljana. We monitored the complications that occurred during the treatment of the patients.
Results. In the above mentioned period 29 patients (24 males and 5 females) were transported from the General Hospital Novo mesto to the KC Ljubljana to have a primary PTCA performed. The total time interval measured between the patients’ arrival to General Hospital Novo mesto to the first inflation of balloon in Ljubljana in the year 2002 was 145 minutes, which is 17 minutes better than in the previous period. The time interval recommended by the guidelines was achieved with four patients.
Conclusions. By recognizing the problems that had encountered with directing the patients from General Hospital Novo mesto to primary PTCA and by solving them, we managed to shorten the door-balloon interval. In the future we will have to improve all the time intervals of handling the patients, which can be accomplished by cooperation of everyone involved in the handling of the patients.
Okrajšek R, Kapš R, Starič S et al. Prevoz bolnikov na primarno PTKA iz Splošne bolnišnice Novo mesto v Ljubljano. Zdrav Vestn 2003; 72: 67–9.
Andersen HR. The Danish multicenter randomized trial on thrombolytic therapy vs. acute coronary angioplasty in acute myocardial infarction. Heart Wire News 2002, Mar. 20.
Anon. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery (C-PORT). JAMA 2002; 287: 1943–51.
Zijlstra F, Patel A, Jones M et al. (for the PCAT collaboration). Clinical characteristics and outcome of patients with early (< 2 h), intermediate (2–4 h) and late (> 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J 2002; 23: 550–7.
Widimský P, Budešínský T, Voráč D et al. Long distance transport for primary angioplasty vs. immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 2003; 24: 94–104.
Noč M, Kranjec I, Pernat A. Akutni koronarni sindrom v Sloveniji. Bled, 2004. Bled: Društvo Iatros, 2004: 1–33.
American Heart Association. 1999 Update: ACC/AHA Guidelines for the management of patient with acute myocardial infarction: Executive summary and recommendations. Circulation 1999; 100: 1016–30.
Widimsky P, Groch L, Zelizko M et al. Multicentre randomized trial comparing transport to primary angioplasty vs. immediate thrombolysis vs. combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 21: 823–31.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.